Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1 10Phase 4 4Phase 3 4Phase 1/2 4Phase NA 3Phase 2/3 2Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1

Conditions

Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Cyclophosphamide 13Methotrexate 12Cytarabine 11Dexamethasone 10Vincristine 9Etoposide 7Radiotherapy 6Mercaptopurine 6Daunorubicin 6Asparaginase 6pegaspargase 5blinatumomab 5Dasatinib 5Prednisone 4Methylprednisolone 4Filgrastim 4Doxorubicin 4ruxolitinib 3N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Busulfan 3Antilymphocyte Serum 3venetoclax 2fludarabine phosphate 2fludarabine 2etoposide phosphate 2calaspargase pegol 2Thiotepa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Stem Cell Transplantation × Clear all
NCT00176839 2017-12-05

Stem Cell Transplantation for Hematological Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2/3 Terminated
11 enrolled 12 charts
LymphoidOther hematologic neoplasm

Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01015742 2012-06-04

Unrelated Double Umbilical Cord Blood Units Transplantation

Tehran University of Medical Sciences

Phase 2/3 Unknown
10 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡